ALFA Finder
India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold
Telegram alerts
alfafinder.com →
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
39 announcements
Jyothy Labs' board approved a Rs 147 Crore share buyback via tender offer at Rs 215 per share. The record date is November 11, 2026.
Q2 EBITDA margin collapsed to 2.5% (16.1% last year) on a 34.8% gross margin. Management gave no numeric guidance and made H2 recovery conditional on commodity stability.
Jyothy Labs posted Q2 FY27 revenue of ₹760 crore and PAT of ₹10.6 crore. H1 FY27 revenue reached ₹1,533 crore with PAT of ₹58.2 crore amid margin pressure.
Q2 FY27 revenue rose 3.3% to ₹760 Cr, but operating EBITDA margin fell to 2.5% and PAT dropped 87.9% to ₹10.6 Cr on raw-material and packaging inflation.
Jyothy Labs Ltd reported revenue from operations of ₹760 Cr (+3.2% YoY) and net profit of ₹10.6 Cr (-87.9% YoY) for Q2 FY27.
Jyothy Labs intimated that its board meets on November 4, 2026 to consider a proposal for buyback of fully paid-up equity shares. Trading window stays closed until 48 hours after the outcome is disclosed.
Jyothy Labs filed its quarterly shareholding pattern. It disclosed an inter-se gift of shares within the promoter group, adding family trusts to the promoter group category.
Jyothy Labs has scheduled its Board of Directors meeting for November 4, 2026. The agenda includes approval of un-audited financial results for Q1 and H1 2026.
Jyothy Labs allotted 21,009 equity shares upon exercise of Restricted Stock Units. This increases the company's total paid-up share capital.
Jyothy Labs received a Rs. 6.63 Crore insurance claim settlement regarding a previously reported warehouse fire incident.
CARE Ratings has reaffirmed Jyothy Labs Limited's 'CARE AA; Stable' rating for its long-term bank facilities. The rating applies to facilities totaling Rs. 250 crore.
Jyothy Labs has granted 1,46,141 Restricted Stock Units (RSUs) to eligible employees under its RSU Plan 2023. These units vest over a period of up to four years.
Nalanda India Equity Fund Limited acquired a 0.85% stake in Jyothy Laboratories Limited. The acquisition of 3,102,384 shares increases the fund's total holding to 7.61%.
Jyothy Labs has been assigned an ESG rating of '67' by NSE Sustainability Ratings & Analytics Limited. This rating was derived independently using public domain data.
Jyothy Labs Limited received an excise duty order demanding ₹20.35 Crore, including penalties and fines. The company plans to appeal against the order, citing previous favorable rulings.
Management is firefighting severe gross margin contraction caused by extreme crude-oil linked inflation, relying on price hikes and channel expansion while facing aggressive competitive discounting.
Jyothy Labs is transferring leasehold rights of its Jammu facility to Alkyam Flexipack Private Limited. The transaction is valued at ₹9.93 Crore.
Jyothy Labs reported Q1 FY27 revenue of ₹773 crore, showing 3.0% year-on-year growth. Operating EBITDA stood at ₹64.7 crore with a margin of 8.4%.
Jyothy Labs reported 3% revenue growth for Q1 FY27, driven by Fabric Care. EBITDA and PAT saw significant declines of 47.9% and 50.8% respectively due to abnormal raw material and packaging inflation.
Jyothy Labs Ltd reported revenue from operations of ₹773.4 Cr (+3.0% YoY) and net profit of ₹47.6 Cr (-50.8% YoY) for Q1 FY27.
Jyothy Labs Limited scheduled a Board meeting on August 12, 2026. The meeting will consider and approve un-audited financial results for the quarter ended June 30, 2026.
CRISIL ESG Rating & Analytics Limited has assigned an ESG rating of 'CRISIL ESG 62' to Jyothy Labs Limited. The rating falls under the 'Strong' category.
Jyothy Labs concluded its 35th AGM on July 14, 2026. Shareholders considered the adoption of financial statements and the declaration of a Rs. 3.50 per share dividend.
Management update on the non-renewal of Henkel brand licenses (Pril and Fa) effective June 1, 2026. Company is shifting focus to scaling 'Exo' Dishwash Liquid and has initiated arbitration in Singapore.
Jyothy Labs' board decided to pursue legal remedies against Henkel over brand license exit terms. Investors should monitor potential litigation impact on brand portfolio.
Jyothy Labs announced the non-renewal of its Pril and Fa license agreements with Henkel beyond 2026. Management is currently evaluating the financial impact of this discontinuation.
Jyothy Labs Limited received an Environmental, Social, and Governance (ESG) rating of '64' from NSE Sustainability Ratings & Analytics Limited. The rating is based on independent analysis of publicly available data from FY 2024-25. This score provides an external assessment of the company's sustainability performance and governance standards for investors.
Jyothy Labs reported Q4FY26 revenue of ₹717cr, up 7.7% YoY, with FY26 revenue at ₹2,944cr. Focus remains on volume-led growth and liquid detergent conversion amid high input cost volatility.
Jyothy Labs Limited submitted its Annual Secretarial Compliance Report for the financial year ended March 31, 2026. Issued by M/s. Rathi & Associates, the report confirms the company's adherence to SEBI regulations and secretarial standards during the review period. No material non-compliances or observations were reported by the practicing company secretary.
Jyothy Labs Limited has recommended a final dividend of ₹3.5 per equity share for FY 2025-26. The record date is set for June 29, 2026, with payment expected by July 18, 2026, subject to shareholder approval at the AGM on July 14, 2026.